Literature DB >> 27037227

Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients.

Barbara Janssen1, Nicoline Voet2, Alexander Geurts1, Baziel van Engelen1, Arend Heerschap1.   

Abstract

OBJECTIVE: To investigate the effects of aerobic exercise training (AET) and cognitive-behavioral therapy (CBT), directed towards an increase in daily physical activity, on the progression of fatty infiltration and edema in skeletal muscles of patients with facioscapulohumeral muscular dystrophy (FSHD) type 1 by T2 MRI.
METHODS: Quantitative T2 MRI (qT2 MRI) and fat-suppressed T2 MRI of the thigh were performed at 3T on 31 patients, 13 of whom received usual care (UC), 9 AET, and 9 CBT. Muscle-specific fat fractions (%), derived from qT2 MRI, were recorded pretreatment and posttreatment. Intervention effects were analyzed by comparing fat fraction progression rates of the UC with the treated groups using Mann-Whitney tests, and intermuscle differences by a linear mixed model. Edematous hyperintense lesions were identified on the fat-suppressed T2 MRI.
RESULTS: The intraclass correlation coefficient for reproducibility of qT2 MRI fat assessment was 0.99. In the UC group, the fat fraction increased by 6.7/year (95% confidence interval [CI] 4.3 to 9.1). This rate decreased to 2.9/year (95% CI 0.7 to 5.2) in the AET (p = 0.03) and 1.7/year (95% CI -0.2 to 3.6) in the CBT group (p = 0.00015). The treatment effect differed among individual muscles. Fewer new edematous lesions occurred after therapy.
CONCLUSIONS: Fat fraction derived from qT2 MRI is a reproducible and sensitive biomarker to monitor the effects of increased physical activity in individual muscles. This biomarker reports a favorable effect of AET and CBT on the rate of muscular deterioration in FSHD as reflected in decelerated fat replacement. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with FSHD type 1, both AET and CBT decrease the rate of fatty infiltration in muscles.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27037227     DOI: 10.1212/WNL.0000000000002640

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

2.  MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.

Authors:  Grete Andersen; Julia R Dahlqvist; Christoffer R Vissing; Karen Heje; Carsten Thomsen; John Vissing
Journal:  J Neurol       Date:  2016-12-20       Impact factor: 4.849

3.  Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Authors:  Karlien Mul; Sanne C C Vincenten; Nicol C Voermans; Richard J L F Lemmers; Patrick J van der Vliet; Silvère M van der Maarel; George W Padberg; Corinne G C Horlings; Baziel G M van Engelen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

4.  High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trial.

Authors:  Grete Andersen; Karen Heje; Astrid Emile Buch; John Vissing
Journal:  J Neurol       Date:  2017-05-03       Impact factor: 4.849

Review 5.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

6.  Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study.

Authors:  Elisa Vegezzi; Andrea Cortese; Laura Obici; Anna Pichiecchio; Niels Bergsland; Roberta Mussinelli; Matteo Paoletti; Francesca Solazzo; Riccardo Currò; Lucia Ascagni; Ilaria Callegari; Ilaria Quartesan; Alessandro Lozza; Xeni Deligianni; Francesco Santini; Enrico Marchioni; Giuseppe Cosentino; Enrico Alfonsi; Cristina Tassorelli; Stefano Bastianello; Giampaolo Merlini; Giovanni Palladini
Journal:  J Neurol       Date:  2022-09-06       Impact factor: 6.682

7.  Interventions for promoting physical activity in people with neuromuscular disease.

Authors:  Katherine Jones; Fiona Hawke; Jane Newman; James Al Miller; Joshua Burns; Djordje G Jakovljevic; Grainne Gorman; Douglass M Turnbull; Gita Ramdharry
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

8.  Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.

Authors:  Farzad Fatehi; Emmanuelle Salort-Campana; Arnaud Le Troter; Emilie Lareau-Trudel; Mark Bydder; Alexandre Fouré; Maxime Guye; David Bendahan; Shahram Attarian
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

9.  Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.

Authors:  Pietro Spitali; Kristina Hettne; Roula Tsonaka; Ekrem Sabir; Alexandre Seyer; Jesse B A Hemerik; Jelle J Goeman; Esther Picillo; Manuela Ergoli; Luisa Politano; Annemieke Aartsma-Rus
Journal:  J Cell Mol Med       Date:  2018-02-14       Impact factor: 5.310

10.  Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.

Authors:  Karlien Mul; Corinne G C Horlings; Sanne C C Vincenten; Nicol C Voermans; Baziel G M van Engelen; Nens van Alfen
Journal:  J Neurol       Date:  2018-09-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.